Effect of prolyl endopeptidase on digestive-resistant gliadin peptides in vivo.
about
Identification and analysis of multivalent proteolytically resistant peptides from gluten: implications for celiac sprueNon-dietary forms of treatment for adult celiac diseaseProtein engineering of improved prolyl endopeptidases for celiac sprue therapyDietary gluten and the development of type 1 diabetesHighly efficient gluten degradation with a newly identified prolyl endoprotease: implications for celiac diseaseHighly efficient gluten degradation by lactobacilli and fungal proteases during food processing: new perspectives for celiac diseaseExtracellular transglutaminase 2 is catalytically inactive, but is transiently activated upon tissue injury.Parallels between pathogens and gluten peptides in celiac sprueAnalysis of wheat prolamins, the causative agents of celiac sprue, using reversed phase high performance liquid chromatography (RP-HPLC) and matrix-assisted laser desorption ionization time of flight mass spectrometry (MALDI-TOF-MS).Novel therapies for coeliac diseaseGeneration of food-grade recombinant Lactobacillus casei delivering Myxococcus xanthus prolyl endopeptidase.Transglutaminase 2 inhibitors and their therapeutic role in disease states.Large Gliadin Peptides Detected in the Pancreas of NOD and Healthy Mice following Oral Administration.Future therapeutic options for celiac disease.Celiac disease: pathogenesis of a model immunogenetic disease.Noninflammatory gluten peptide analogs as biomarkers for celiac sprue.Rapid isolation of gluten-digesting bacteria from human stool and saliva by using gliadin-containing plates.Supplementation of Reduced Gluten Barley Diet with Oral Prolyl Endopeptidase Effectively Abrogates Enteropathy-Associated Changes in Gluten-Sensitive MacaquesRandomised clinical study: Aspergillus niger-derived enzyme digests gluten in the stomach of healthy volunteers.Future treatment strategies for celiac disease.Targeted modification of wheat grain protein to reduce the content of celiac causing epitopes.Current status of drugs in development for celiac disease.2-Indolinone a versatile scaffold for treatment of cancer: a patent review (2008-2014).Dietary gluten increases natural killer cell cytotoxicity and cytokine secretion.Interferon-gamma released by gluten-stimulated celiac disease-specific intestinal T cells enhances the transepithelial flux of gluten peptides.Self-assembly of 33-mer gliadin peptide oligomers.New and developing therapies for celiac disease.Oral enzyme therapy for celiac sprue.Structure-based design of alpha-amido aldehyde containing gluten peptide analogues as modulators of HLA-DQ2 and transglutaminase 2.Identification and characterization of intestinal lactobacilli strains capable of degrading immunotoxic peptides present in gluten.Development and optimisation of a generic micro LC-ESI-MS method for the qualitative and quantitative determination of 30-mer toxic gliadin peptides in wheat flour for food analysis.A modular electrochemical peptide-based sensor for antibody detection.Gluten-free diet increases beta-cell volume and improves glucose tolerance in an animal model of type 2 diabetes.Letter: gluten digestion in the stomach and duodenum by Aspergillus niger-derived enzyme - things to ponder.
P2860
Q24538575-195E4701-F68E-4C90-9CC6-88C9364B71E5Q24602271-EF81B079-872E-4183-8DA4-A2DF709C3135Q24657645-7164D60F-37C2-4A24-90DD-4F6EAF68DCC3Q26823584-0EFD0027-C4D7-49F5-9740-C0C4226DDF37Q28239734-5C9F5A53-D5E7-43F0-88BF-B611AAF1DD11Q33285135-64466BD0-2FED-4A38-9C65-6A5CC2CA4D88Q33325485-F26AFBA3-5CB4-437F-A26F-C857D013E999Q33329537-EDE7E2D9-7607-466C-A6BA-6A7F02038799Q33570451-9C50AD86-C5A7-4F4F-8F1A-0FC9904756A6Q34170574-741337CE-5993-4ECC-8DBF-6443D1AC8BF2Q34661417-476FC210-B581-483F-9539-680A5B4B7CD0Q35989247-8501D874-6821-499C-B133-DF01B0AFCA37Q36178076-890D9B40-2DFE-428B-B089-A87D78165D52Q36304110-1B27977A-8A81-415A-BBB4-879EA8451108Q36698131-BA54D1EB-D472-4971-85B7-215A5D134063Q37041073-2616708B-F750-4EF5-9D13-241F909D4F08Q37071537-8EF2270F-5103-40E2-B157-CD28F4281967Q37133010-A24ACB68-0DBE-40F2-8215-26A61D16058EQ37275552-EC6B6DE1-5FC0-4583-BED0-BDC2282E8251Q38012460-47E2723B-AD44-4907-9E34-DFAC63E0DAACQ38021639-7600B406-8F10-4FF7-BF9E-8131D3A3A7F5Q38210088-8068C3F6-0605-43F3-80AE-CE437DF4FE79Q38631566-DA79A83D-23E6-43EF-9273-3CA82E83EF6EQ38973710-A7BB5F1D-50FC-4BF1-8DEF-88C3ABD52806Q39883644-9C65F7A1-8E41-48AB-9FC9-6F571B1C4B4FQ40533591-E144C80B-2F55-4699-9DCA-A833BCDD1ED4Q41173044-F53878D8-33E1-498D-BD1D-24BD3B632A4DQ42212923-0F554F36-19D6-4265-86A0-BB9A0C79CDDEQ42245644-A8132BF3-4ABC-4E56-BDDA-233BCFA055D9Q46817256-0B6F74DE-6828-4C9B-BD19-B7745D600881Q50129080-7117BEFB-77F0-4F87-AC3A-ADDADEF2CC81Q50426523-321B0B7E-AD28-4092-A4D2-AADBCAA28588Q51287171-14506BA7-9328-469E-B4DE-581C644A3D05Q53790331-12B77FA2-C1EC-4ACA-9D91-A6E2DDB85989
P2860
Effect of prolyl endopeptidase on digestive-resistant gliadin peptides in vivo.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Effect of prolyl endopeptidase on digestive-resistant gliadin peptides in vivo.
@en
Effect of prolyl endopeptidase on digestive-resistant gliadin peptides in vivo.
@nl
type
label
Effect of prolyl endopeptidase on digestive-resistant gliadin peptides in vivo.
@en
Effect of prolyl endopeptidase on digestive-resistant gliadin peptides in vivo.
@nl
prefLabel
Effect of prolyl endopeptidase on digestive-resistant gliadin peptides in vivo.
@en
Effect of prolyl endopeptidase on digestive-resistant gliadin peptides in vivo.
@nl
P2093
P356
P1476
Effect of prolyl endopeptidase on digestive-resistant gliadin peptides in vivo.
@en
P2093
Chaitan Khosla
Gary M Gray
Justin L Piper
P304
P356
10.1124/JPET.104.068429
P407
P577
2004-05-13T00:00:00Z